Mirae Asset Global Etfs Holdings Ltd. Prothena Corp Public LTD CO Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,269 shares of PRTA stock, worth $358,314. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,269
Previous 25,718
6.03%
Holding current value
$358,314
Previous $430,000
12.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PRTA
# of Institutions
197Shares Held
39.3MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$152 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$50.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$48.4 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$29.4 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$24.5 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $617M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...